Treatments for gastrointestinal stromal tumors that are resistant to standard therapies.
about
The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response.Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions.
P2860
Treatments for gastrointestinal stromal tumors that are resistant to standard therapies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Treatments for gastrointestinal stromal tumors that are resistant to standard therapies.
@en
type
label
Treatments for gastrointestinal stromal tumors that are resistant to standard therapies.
@en
prefLabel
Treatments for gastrointestinal stromal tumors that are resistant to standard therapies.
@en
P2860
P50
P356
P1433
P1476
Treatments for gastrointestinal stromal tumors that are resistant to standard therapies.
@en
P2860
P304
P356
10.2217/FON.14.109
P407
P577
2014-10-01T00:00:00Z